Karuna Therapeutics to Present at the SVB Securities Global Biopharma ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 25, 2024

OPAL Fuels Announces First Quarter 2024 Earnings Release Date and Conference Call • New Research from Material and NewtonX Reveals Shifts in Digital Ad Spending and Social Media Strategies • PharMerica Donates 719,287 Prescriptions to Underserved Patients in 2023 • AACN’s New Web Resource Focuses on Preparing Nurses with Essential Well-Being and Leadership Competencies • Snap Inc. Announces First Quarter 2024 Financial Results • Hyosung TNC presents a new paradigm through sustainable bio BDO production. • Yeshiva University Launches Accelerated Transfer Initiative for Students Who Feel Threatened at Current Universities • KB Home Announces the Grand Opening of Its Newest Community Within the Highly Desirable Stanford Crossing Master Plan in Lathrop • Babcock & Wilcox Sets First Quarter 2024 Conference Call and Webcast for Thursday, May 9, 2024 at 5 p.m. ET • Lucidea Press Releases New Museum CMS Title Demystifying Data Preparation • AGNICO EAGLE REPORTS FIRST QUARTER 2024 RESULTS - STRONG QUARTERLY GOLD PRODUCTION AND COST PERFORMANCE DRIVE RECORD QUARTERLY F • Statement by the First Nations Leadership Council and Ministers Hajdu and Anandasangaree following their participation at Our Ga • National Institutes of Health All of Us Research Program Mobile Tour Visits California • Rap Snacks Joins Forces with Hip Hop Superstars, Quavo and Parlae, to Support Huncho Elite 7v7 Program and 7th Annual Huncho Day • Freeport-McMoRan Publishes 2023 Annual Report on Sustainability • Metro Storage LLC Invests in Sustainable Future with Rooftop Solar Energy Panels • AHF Praises Colombia for Putting Lives Before Pharma Greed • National Animation Museum Announces Collaboration with The Children's Museum of Indianapolis • LA Pride Unveils "Pride is Universal" LGBTQ+ Event at Universal Studios Hollywood on June 15 • FanttikRide Unveils Officially Licensed Mercedes Benz AMG G63 Miniature Car for Kids

Karuna Therapeutics to Present at the SVB Securities Global Biopharma Conference

BOSTON , February 09 /Businesswire/ - Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 2:20 p.m. EST.

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the conference.

About Karuna

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.